Neopanaxadiol, an aglycone of protopanaxadiol type ginsenosides, has the potential for Alzheimer's disease research.

Neopanaxadiol (30 mg/kg; oral) has a T 1/2 of 2.52 hours, a CL of 5.44 L/h?kg, a C max of 913.44 ng/mL in dogs[1].

1203590-03-7

C30H52O3

460.73

Neopanaxadiol

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years